Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bayer Aktienges ADR
(OP:
BAYRY
)
13.35
+0.09 (+0.71%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 10, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
650,998
Open
13.40
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
13.26
Today's Range
13.30 - 13.43
52wk Range
12.45 - 18.45
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
FDA Approves Expanded Use For Bayer's Prostate Cancer Drug
August 08, 2022
Via
Benzinga
This Biotech Says Stem Cells May Be Key To Freeing 65 Million Americans From Chronic Back Pain, Painkiller Dependence
July 27, 2022
BioRestorative Therapies Inc. (NASDAQ: BRTX), a stem cell-focused biotech, says it wants to shift the paradigm of how doctors treat chronic pain in hopes of giving patients an option that’s effective,...
Via
Benzinga
Performance
YTD
-0.82%
-0.82%
1 Month
-4.91%
-4.91%
3 Month
-18.70%
-18.70%
6 Month
-12.17%
-12.17%
1 Year
-3.61%
-3.61%
More News
Read More
Why Is Ginkgo Bioworks (DNA) Stock in the Spotlight Today?
July 25, 2022
Via
InvestorPlace
Science Wednesday: 'Silent Spring' At 60; Preserved Baby Mammoth Found In Yukon; Filling Medical Imaging, Nursing Shortages
June 29, 2022
Via
Benzinga
BWXT Medical, Bayer Ink Commercial Agreement For Actinium-225 Based Products
June 27, 2022
Via
Benzinga
SpringWorks Therapeutics Shares Jump On HC Wainwright Bullish Pitch
June 13, 2022
Via
Benzinga
Read Why Did HC Wainwright Cut Price Target On Atara Biotherapeutics
May 23, 2022
Via
Benzinga
Recap: Bayer Q4 Earnings
March 01, 2022
Via
Benzinga
7 Blue-Chip Stocks to Buy Now if You Have $250 to Spend
June 08, 2022
Via
InvestorPlace
Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off
June 01, 2022
Via
Benzinga
Three Stocks To Buy In This Bear Market
May 30, 2022
Via
Talk Markets
The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
May 20, 2022
Via
Benzinga
Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
May 20, 2022
Via
Benzinga
How Heart Drugs Could Pump $10 Billion Into Merck's Coffers
May 19, 2022
Via
Investor's Business Daily
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Via
Benzinga
22nd Century Group Reports Q1 Net Sales Of $9M, Up 33% YoY, Net Loss Also Grows
May 05, 2022
Via
Benzinga
Investment Strategy Monthly Insights, April 2022
April 22, 2022
Via
Talk Markets
FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
April 21, 2022
Via
Benzinga
Merck Projects $10 Billion From Its Next Blockbuster Segment; Will It Measure Up?
April 05, 2022
Via
Investor's Business Daily
What Stocks Do Well During a Bear Market? 7 Picks for a Downturn
March 16, 2022
Via
InvestorPlace
Eli Lilly To Suspend Sale Of 'Non-Essential' Medicines To Russia
March 15, 2022
Via
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Via
Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Via
Benzinga
Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?
February 17, 2022
Via
Investor's Business Daily
Aveo Says Tivozanib Patients Up To 5X More Likely To Experience Long-Term PFS Vs. Nexavar In Kidney Cancer
February 15, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.